Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077391034> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2077391034 endingPage "523" @default.
- W2077391034 startingPage "521" @default.
- W2077391034 abstract "Natalizumab is a humanized monoclonal antibody against alpha-4 integrin. It prevents inflammatory cells from crossing vascular endothelial cells into the CNS and mucosal organs.1 Natalizumab is approved for the treatment of relapsing multiple sclerosis (MS).2 There are reports of opportunistic infections that can limit its use.3The diploid fungus Candida albicans may cause opportunistic cutaneous infections, with an estimated prevalence of 0.2% in a healthy European population4 and 3.7% in a sample of immunocompromised patients.5 Severe cutaneous Candida infections may occur in immunocompromised patients, such as those with HIV, chemotherapy, cancer, or organ transplantation.5We report a 61-year-old woman with relapsing MS who presented with a severe cutaneous Candida infection during treatment with natalizumab.### Level of evidence.This is a single case report of severe adverse event. It is level IV evidence.### Case report.In August 2008, a 61-year-old woman with MS developed an itchy redness in her inguinal, genital, axillary, and lumbar regions, a few days after her 11th natalizumab infusion. This was diagnosed as cutaneous Candida infection. Within 14 days, over 30% of her body surface was covered by Candida , with multiple ulcerations in the infected gluteal region.In August 2007, the patient had been diagnosed with relapsing-remitting MS with an Expanded Disability Status Scale score of 5.5. …" @default.
- W2077391034 created "2016-06-24" @default.
- W2077391034 creator A5010798008 @default.
- W2077391034 creator A5030466498 @default.
- W2077391034 creator A5037539121 @default.
- W2077391034 creator A5038269082 @default.
- W2077391034 creator A5044499506 @default.
- W2077391034 creator A5053357133 @default.
- W2077391034 date "2010-02-08" @default.
- W2077391034 modified "2023-09-25" @default.
- W2077391034 title "SEVERE CUTANEOUS CANDIDA INFECTION DURING NATALIZUMAB THERAPY IN MULTIPLE SCLEROSIS" @default.
- W2077391034 doi "https://doi.org/10.1212/wnl.0b013e3181cef810" @default.
- W2077391034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20142621" @default.
- W2077391034 hasPublicationYear "2010" @default.
- W2077391034 type Work @default.
- W2077391034 sameAs 2077391034 @default.
- W2077391034 citedByCount "25" @default.
- W2077391034 countsByYear W20773910342012 @default.
- W2077391034 countsByYear W20773910342013 @default.
- W2077391034 countsByYear W20773910342016 @default.
- W2077391034 countsByYear W20773910342017 @default.
- W2077391034 countsByYear W20773910342018 @default.
- W2077391034 countsByYear W20773910342019 @default.
- W2077391034 countsByYear W20773910342020 @default.
- W2077391034 countsByYear W20773910342021 @default.
- W2077391034 countsByYear W20773910342023 @default.
- W2077391034 crossrefType "journal-article" @default.
- W2077391034 hasAuthorship W2077391034A5010798008 @default.
- W2077391034 hasAuthorship W2077391034A5030466498 @default.
- W2077391034 hasAuthorship W2077391034A5037539121 @default.
- W2077391034 hasAuthorship W2077391034A5038269082 @default.
- W2077391034 hasAuthorship W2077391034A5044499506 @default.
- W2077391034 hasAuthorship W2077391034A5053357133 @default.
- W2077391034 hasConcept C16005928 @default.
- W2077391034 hasConcept C203014093 @default.
- W2077391034 hasConcept C2779548794 @default.
- W2077391034 hasConcept C2780640218 @default.
- W2077391034 hasConcept C2780644213 @default.
- W2077391034 hasConcept C2781004633 @default.
- W2077391034 hasConcept C2909938017 @default.
- W2077391034 hasConcept C71924100 @default.
- W2077391034 hasConceptScore W2077391034C16005928 @default.
- W2077391034 hasConceptScore W2077391034C203014093 @default.
- W2077391034 hasConceptScore W2077391034C2779548794 @default.
- W2077391034 hasConceptScore W2077391034C2780640218 @default.
- W2077391034 hasConceptScore W2077391034C2780644213 @default.
- W2077391034 hasConceptScore W2077391034C2781004633 @default.
- W2077391034 hasConceptScore W2077391034C2909938017 @default.
- W2077391034 hasConceptScore W2077391034C71924100 @default.
- W2077391034 hasIssue "6" @default.
- W2077391034 hasLocation W20773910341 @default.
- W2077391034 hasLocation W20773910342 @default.
- W2077391034 hasOpenAccess W2077391034 @default.
- W2077391034 hasPrimaryLocation W20773910341 @default.
- W2077391034 hasRelatedWork W1991259419 @default.
- W2077391034 hasRelatedWork W2020949546 @default.
- W2077391034 hasRelatedWork W2033461473 @default.
- W2077391034 hasRelatedWork W2053771050 @default.
- W2077391034 hasRelatedWork W2077391034 @default.
- W2077391034 hasRelatedWork W2081527553 @default.
- W2077391034 hasRelatedWork W228581436 @default.
- W2077391034 hasRelatedWork W2586672174 @default.
- W2077391034 hasRelatedWork W2818147527 @default.
- W2077391034 hasRelatedWork W95447500 @default.
- W2077391034 hasVolume "74" @default.
- W2077391034 isParatext "false" @default.
- W2077391034 isRetracted "false" @default.
- W2077391034 magId "2077391034" @default.
- W2077391034 workType "article" @default.